# Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria

> **NCT02238249** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 122 (actual)

## Conditions studied

- Urticaria

## Interventions

- **DRUG:** Alesion®

## Key facts

- **NCT ID:** NCT02238249
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-09
- **Final completion:** —
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02238249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02238249, "Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02238249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*